BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $605,046 | -24.8% | 16,032 | -9.3% | 0.02% | -26.1% |
| Q2 2023 | $805,090 | +15.6% | 17,671 | +2.9% | 0.02% | +9.5% |
| Q1 2023 | $696,536 | +79961.6% | 17,173 | +0.6% | 0.02% | -22.2% |
| Q4 2022 | $870 | -99.9% | 17,069 | -49.9% | 0.03% | -15.6% |
| Q3 2022 | $918,918 | -2.8% | 34,082 | +131.7% | 0.03% | 0.0% |
| Q2 2022 | $945,000 | +287.3% | 14,710 | +384.5% | 0.03% | +255.6% |
| Q3 2021 | $244,000 | 0.0% | 3,036 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $244,000 | -5.1% | 3,036 | -0.5% | 0.01% | -10.0% |
| Q1 2021 | $257,000 | +5.3% | 3,051 | +0.5% | 0.01% | 0.0% |
| Q4 2020 | $244,000 | 0.0% | 3,036 | 0.0% | 0.01% | -16.7% |
| Q3 2020 | $244,000 | -10.6% | 3,036 | -4.4% | 0.01% | -14.3% |
| Q2 2020 | $273,000 | +5.8% | 3,176 | 0.0% | 0.01% | -12.5% |
| Q1 2020 | $258,000 | -13.7% | 3,176 | -11.2% | 0.02% | +6.7% |
| Q4 2019 | $299,000 | -9.4% | 3,576 | -5.0% | 0.02% | -11.8% |
| Q3 2019 | $330,000 | +6.8% | 3,766 | 0.0% | 0.02% | +6.2% |
| Q2 2019 | $309,000 | -20.8% | 3,766 | -21.6% | 0.02% | -20.0% |
| Q1 2019 | $390,000 | +7.1% | 4,802 | -13.0% | 0.02% | 0.0% |
| Q4 2018 | $364,000 | +0.3% | 5,519 | +17.5% | 0.02% | +11.1% |
| Q3 2018 | $363,000 | -7.6% | 4,699 | -11.6% | 0.02% | -10.0% |
| Q2 2018 | $393,000 | +39.4% | 5,315 | +22.5% | 0.02% | +33.3% |
| Q1 2018 | $282,000 | -0.7% | 4,338 | -1.3% | 0.02% | 0.0% |
| Q4 2017 | $284,000 | -2.1% | 4,394 | -4.9% | 0.02% | -6.2% |
| Q3 2017 | $290,000 | +7.0% | 4,618 | +3.2% | 0.02% | +6.7% |
| Q2 2017 | $271,000 | -35.2% | 4,475 | -44.5% | 0.02% | -34.8% |
| Q1 2017 | $418,000 | +15.2% | 8,065 | -1.4% | 0.02% | +9.5% |
| Q4 2016 | $363,000 | -14.4% | 8,179 | -8.1% | 0.02% | -12.5% |
| Q3 2016 | $424,000 | +1.2% | 8,902 | -3.9% | 0.02% | 0.0% |
| Q2 2016 | $419,000 | +8.8% | 9,266 | -1.0% | 0.02% | +4.3% |
| Q1 2016 | $385,000 | -7.5% | 9,360 | -14.2% | 0.02% | -8.0% |
| Q4 2015 | $416,000 | -32.0% | 10,905 | -41.5% | 0.02% | -32.4% |
| Q3 2015 | $612,000 | -46.3% | 18,654 | +14.6% | 0.04% | -42.2% |
| Q2 2015 | $1,139,000 | +5.9% | 16,284 | +3.6% | 0.06% | +8.5% |
| Q1 2015 | $1,076,000 | +7.7% | 15,717 | +15.3% | 0.06% | -7.8% |
| Q4 2014 | $999,000 | +2.0% | 13,630 | -0.1% | 0.06% | 0.0% |
| Q3 2014 | $979,000 | +23.3% | 13,642 | +24.3% | 0.06% | +6.7% |
| Q2 2014 | $794,000 | +134.9% | 10,975 | +139.0% | 0.06% | +93.5% |
| Q1 2014 | $338,000 | +5.0% | 4,593 | -0.8% | 0.03% | +6.9% |
| Q4 2013 | $322,000 | +6.6% | 4,629 | +0.7% | 0.03% | -6.5% |
| Q3 2013 | $302,000 | -2.6% | 4,598 | +2.7% | 0.03% | -6.1% |
| Q2 2013 | $310,000 | – | 4,476 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |